Filter by: Subject

Filter by: Subject

Results Per Page:

PSA response (3)
225Ac-PSMA-617 (2)
68Ga-PSMA (2)
Breast cancer (2)
Cervical cancer (2)
Computed tomography (CT) (2)
Hypoxia (2)
Immunohistochemistry (2)
Metastatic castration-resistant prostate cancer (mCRPC) (2)
Positron emission tomography/computed tomography (PET/CT) (2)
Principal component analysis (PCA) (2)
Radiomics (2)
Therapy response (2)
Tuberculosis (TB) (2)
18F-FDG (1)
18F-fuorodeoxyglucose (FDG) (1)
225Ac-PSMA (1)
68Ga-citrate (1)
68Ga-Nitroimidazole (1)
[68Ga]Ga-FAPI PET/CT (1)
Androgen deprivation treatment (ADT) (1)
Behandlung (1)
Benign vs. malignant (1)
Bins (1)
Bioassay (1)
Biomaterials (1)
Black South-African (BSAs) (1)
Blood–brain barrier (BBB) (1)
Bone SPECT-CT (1)
Carcinoma, squamous cell (1)
Characterization (1)
Chelation (1)
Chemical analysis (1)
Chemical modification (1)
Chromatography (1)
Colorectal cancer (1)
Computerized tomography (CT) (1)
Computerized tomography' (CT) (1)
Cryptic peptides (1)
Dichroism (1)
Drug products (1)
FAPI tumor volume (FAPI-TV) (1)
FDG PET/CT (1)
FDG-PET (1)
FDG-PET imaging (1)
Fludeoxyglucose (FDG) (1)
Fluorine-18-Fluorodeoxyglucose (FDG) (1)
Fluorodeoxyglucose F18 (1)
Fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) (1)
Fluorodeoxyglucose-positron emission tomography (FDG PET) (1)
Functional characterization (1)
Gastro-intestinal cancer (1)
GHR bioassay (1)
Growth hormone receptor (GHR) (1)
Health sciences article SDG-03 (1)
Highly active antiretroviral therapy (HAART) (1)
HIV infection (1)
HIV infections (1)
Human growth hormone (1)
Human immunodeficiency virus (HIV) (1)
Hypoxia inducible factor-1 (HIF-1) (1)
Hypoxia-inducible factor-1alpha (HIF-1) (1)
Hypoxic tumor volume (HTV) (1)
Immunohistochemistry (IHC) (1)
Inherent complexity (1)
Intra-tumoral heterogeneity (1)
Isomers (1)
LIFEx software (1)
Lipodystrophy (1)
Logistic binomial regression (1)
Loosening (1)
Lumbar fusion (1)
Lung lesions (1)
Mass spectrometry (1)
Medical imaging (1)
Melanoma (1)
Metabolic tumor volume (MTV) (1)
Metastatic hormone-sensitive prostate carcinoma (mHSPC) (1)
Metastatic prostate carcinoma (1)
Multiple substitutions (1)